SENS RSI Chart
Last 7 days
4.3%
Last 30 days
22.5%
Last 90 days
-31.9%
Trailing 12 Months
-34.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 23.3M | 0 | 0 | 0 |
2023 | 18.0M | 18.5M | 19.9M | 22.4M |
2022 | 13.3M | 13.7M | 14.8M | 16.4M |
2021 | 7.8M | 10.8M | 13.6M | 13.7M |
2020 | 17.2M | 13.1M | 9.0M | 4.9M |
2019 | 19.4M | 20.4M | 19.5M | 21.3M |
2018 | 8.8M | 11.6M | 14.6M | 18.9M |
2017 | 885.0K | 1.7M | 3.7M | 6.4M |
2016 | 0 | 77.0K | 91.0K | 365.0K |
2015 | 0 | 61.2K | 41.6K | 73.0K |
2014 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 02, 2024 | fiorentino edward | acquired | 14,125 | 0.51 | 27,696 | - |
Apr 02, 2024 | steven edelman | acquired | 12,875 | 0.51 | 25,245 | - |
Apr 02, 2024 | prince douglas s | acquired | 8,124 | 0.51 | 15,931 | - |
Jan 02, 2024 | prince douglas s | acquired | 8,124 | 0.56 | 14,508 | - |
Jan 02, 2024 | fiorentino edward | acquired | 14,124 | 0.56 | 25,223 | - |
Jan 02, 2024 | defalco stephen p | acquired | 23,749 | 0.56 | 42,410 | - |
Jan 02, 2024 | steven edelman | acquired | 12,875 | 0.56 | 22,991 | - |
Nov 15, 2023 | sullivan frederick t. | sold (taxes) | -62,453 | 0.61 | -102,383 | chief financial officer |
Nov 15, 2023 | kaufman francine | sold (taxes) | -70,703 | 0.61 | -115,908 | chief medical officer |
Nov 15, 2023 | jain mukul | sold (taxes) | -162,814 | 0.61 | -266,908 | chief operating officer |
Which funds bought or sold SENS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -56.7 | -49,442 | 33,426 | -% |
May 16, 2024 | Semmax Financial Advisors Inc. | unchanged | - | -165 | 489 | -% |
May 15, 2024 | Point72 Asset Management, L.P. | added | 42.18 | 113,620 | 463,756 | -% |
May 15, 2024 | STATE STREET CORP | added | 7.06 | -2,638 | 1,004,050 | -% |
May 15, 2024 | MORGAN STANLEY | added | 61.08 | 64,859 | 194,424 | -% |
May 15, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | added | 16.13 | 15,000 | 196,000 | -% |
May 15, 2024 | AXA S.A. | unchanged | - | -46,746 | 636,576 | -% |
May 15, 2024 | Tudor Investment Corp Et Al | unchanged | - | -6,801 | 92,615 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -0.13 | -9,285 | 124,114 | -% |
May 15, 2024 | Mariner, LLC | reduced | -18.2 | -3,565 | 11,419 | -% |
Unveiling Senseonics Holdings Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Senseonics Holdings Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Senseonics Holdings Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -37.1% | 5.00 | 8.00 | 6.00 | 4.00 | 4.00 | 6.00 | 5.00 | 4.00 | 2.00 | 4.00 | 4.00 | 3.00 | 3.00 | 4.00 | 1.00 | 0.00 | 5.00 | 9.00 | 4.00 | 5.00 | 3.00 |
Gross Profit | -69.5% | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | -0.47 | -1.25 | 0.00 | 1.00 | 3.00 | 1.00 | -1.14 | -19.63 | -8.24 | -3.34 | -4.55 | -3.31 |
S&GA Expenses | 10.7% | 8.00 | 7.00 | 7.00 | 7.00 | 8.00 | 8.00 | 7.00 | 9.00 | 8.00 | 8.00 | 8.00 | 9.00 | 2.00 | 24.00 | 3.00 | 3.00 | 11.00 | 11.00 | 12.00 | 14.00 | 13.00 |
R&D Expenses | -2.9% | 10.00 | 11.00 | 13.00 | 13.00 | 12.00 | 12.00 | 11.00 | 9.00 | 8.00 | 8.00 | 7.00 | 7.00 | 5.00 | 5.00 | 5.00 | 4.00 | 7.00 | 10.00 | 11.00 | 11.00 | 7.00 |
Interest Expenses | -23.2% | 1.00 | 2.00 | 2.00 | 2.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 4.00 | 4.00 | 4.00 | 8.00 | 0.00 | 2.00 | 2.00 |
Net Income | -9.8% | -18.88 | -17.19 | -24.10 | -20.42 | 1.00 | 12.00 | -60.39 | 104 | 87.00 | 84.00 | 43.00 | -180 | -249 | -101 | -23.43 | -7.51 | -42.59 | -35.61 | -19.50 | -31.07 | -29.36 |
Net Income Margin | -28.2% | -3.46* | -2.70* | -1.59* | -3.68* | 3.14* | 8.67* | 14.50* | 23.17* | 2.54* | -22.12* | -36.05* | -51.44* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -34.5% | -20.26 | -15.07 | -17.26 | -17.98 | -19.85 | -17.39 | -14.58 | -14.18 | -20.16 | -11.80 | -13.87 | -14.15 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -8.5% | 127 | 138 | 154 | 153 | 159 | 178 | 183 | 175 | 188 | 199 | 220 | 235 | 196 | 36.00 | 44.00 | 41.00 | 35.00 | 133 | 167 | 98.00 | 129 |
Current Assets | -9.1% | 118 | 130 | 146 | 138 | 146 | 161 | 169 | 158 | 161 | 144 | 158 | 179 | 191 | 30.00 | 36.00 | 32.00 | 31.00 | 128 | 162 | 94.00 | 125 |
Cash Equivalents | 20.0% | 91.00 | 76.00 | 56.00 | 29.00 | 45.00 | 36.00 | 35.00 | 45.00 | 39.00 | 33.00 | 46.00 | 70.00 | 179 | 18.00 | 26.00 | 22.00 | 19.00 | 96.00 | 131 | 65.00 | 104 |
Inventory | -9.3% | 8.00 | 9.00 | 10.00 | 9.00 | 8.00 | 7.00 | 7.00 | 7.00 | 7.00 | 6.00 | 8.00 | 9.00 | 7.00 | 5.00 | 4.00 | 4.00 | 5.00 | 17.00 | 20.00 | 17.00 | 14.00 |
Net PPE | 21.3% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Liabilities | 7.9% | 70.00 | 65.00 | 64.00 | 63.00 | 56.00 | 143 | 198 | 159 | 278 | 384 | 486 | 548 | 382 | 177 | 96.00 | 80.00 | 84.00 | 141 | 142 | 83.00 | 85.00 |
Current Liabilities | 72.8% | 30.00 | 17.00 | 17.00 | 16.00 | 14.00 | 31.00 | 58.00 | 31.00 | 31.00 | 18.00 | 20.00 | 20.00 | 16.00 | 17.00 | 10.00 | 12.00 | 18.00 | 127 | 22.00 | 34.00 | 27.00 |
Long Term Debt | -17.6% | 34.00 | 41.00 | 40.00 | 39.00 | 25.00 | 56.00 | 53.00 | 51.00 | 48.00 | 60.00 | 57.00 | 55.00 | 53.00 | 57.00 | 60.00 | 61.00 | - | 12.00 | - | - | - |
Shareholder's Equity | -47.0% | 19.00 | 36.00 | 52.00 | 53.00 | 64.00 | -2.58 | - | 16.00 | - | - | - | - | - | - | - | - | - | - | 25.00 | 15.00 | 44.00 |
Retained Earnings | -2.2% | -888 | -869 | -852 | -827 | -807 | -808 | -820 | -760 | -864 | -950 | -1,035 | -1,078 | -898 | -648 | -546 | -523 | -515 | -473 | -437 | -418 | -387 |
Additional Paid-In Capital | 0.2% | 907 | 905 | 904 | 880 | 872 | 806 | 806 | 777 | 775 | 765 | 768 | 765 | 712 | 504 | 492 | 484 | 467 | 464 | 463 | 433 | 431 |
Shares Outstanding | 0.1% | 531 | 530 | 528 | 493 | 480 | 480 | 464 | 460 | 456 | 447 | 445 | 432 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 357 | - | - | - | 463 | - | - | - | 1,660 | - | - | - | 74.00 | - | - | - | 217 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -34.5% | -20,262 | -15,067 | -17,264 | -17,984 | -19,848 | -17,387 | -14,584 | -14,182 | -20,159 | -11,803 | -13,868 | -14,149 | -16,258 | -8,248 | -13,397 | -16,729 | -29,048 | -34,561 | -35,631 | -35,703 | -30,152 |
Share Based Compensation | -7.1% | 1,801 | 1,938 | 2,084 | 2,870 | 1,781 | 2,075 | 2,222 | 2,585 | 1,736 | 1,895 | 2,413 | 2,981 | 1,740 | 1,733 | 2,303 | 1,409 | 1,869 | 1,600 | 2,195 | 2,232 | 2,025 |
Cashflow From Investing | -29.9% | 25,379 | 36,195 | 27,647 | -4,076 | 29,947 | 7,350 | -22,576 | 22,442 | 19,666 | 6,244 | -9,675 | -145,307 | -11.00 | - | -3.00 | -78.00 | -100 | -94.00 | -215 | -246 | -490 |
Cashflow From Financing | 951.8% | 10,034 | -1,178 | 16,825 | 5,526 | -807 | 10,346 | 27,219 | -1,846 | 6,043 | -7,191 | - | 50,600 | 176,674 | 61.00 | 18,195 | 19,599 | -47,985 | 13.00 | 101,130 | -2,430 | -2,476 |
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue, net | $ 5,047 | $ 4,137 |
Cost of sales | 4,712 | 3,723 |
Gross profit | 335 | 414 |
Expenses: | ||
Research and development expenses | 10,438 | 12,405 |
Selling, general and administrative expenses | 8,129 | 7,718 |
Operating loss | (18,232) | (19,709) |
Other (expense) income, net: | ||
Interest income | 1,384 | 1,108 |
Exchange related gain, net | 18,776 | |
Interest expense | (2,047) | (4,652) |
Gain on change in fair value of derivatives | 5,778 | |
Other income | 18 | 23 |
Total other (expense) income, net | (645) | 21,033 |
Net (Loss) Income | (18,877) | 1,324 |
Other comprehensive income | ||
Unrealized gain on marketable securities | 9 | 458 |
Total other comprehensive gain | 9 | 458 |
Total comprehensive (loss) income | $ (18,868) | $ 1,782 |
Basic net (loss) income per common share | $ (0.03) | $ 0.00 |
Basic weighted-average shares outstanding | 614,588,546 | 497,473,222 |
Diluted net (loss) income per common share | $ (0.03) | $ 0.00 |
Diluted weighted-average shares outstanding | 614,588,546 | 540,532,813 |
Nonrelated Party | ||
Revenue, net | $ 589 | $ 313 |
Related Party | ||
Revenue, net | $ 4,458 | $ 3,824 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 90,544 | $ 75,709 |
Restricted cash | 316 | |
Short term investments, net | 8,169 | 33,747 |
Inventory, net | 7,963 | 8,776 |
Prepaid expenses and other current assets | 7,434 | 7,266 |
Total current assets | 118,177 | 130,030 |
Deposits and other assets | 6,903 | 7,006 |
Property and equipment, net | 1,436 | 1,184 |
Total assets | 126,516 | 138,220 |
Current liabilities: | ||
Accounts payable | 675 | 4,568 |
Note payable, current portion, net | 17,937 | |
Derivative liability, current portion | 102 | |
Total current liabilities | 29,819 | 17,257 |
Long-term debt and notes payables, net | 33,965 | 41,195 |
Derivative liabilities | 102 | |
Other liabilities | 6,114 | 6,214 |
Total liabilities | 69,898 | 64,768 |
Preferred stock and additional paid-in-capital, subject to possible redemption: $0.001 par value per share; 12,000 shares and 12,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023 | 37,656 | 37,656 |
Total temporary equity | 37,656 | 37,656 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Common stock, $0.001 par value per share; 900,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 530,817,549 shares and 530,364,237 shares issued and outstanding as of March 31, 2024 and December 31, 2023 | 530 | 530 |
Additional paid-in capital | 906,569 | 904,535 |
Accumulated other comprehensive loss | (2) | (11) |
Accumulated deficit | (888,135) | (869,258) |
Total stockholders' equity | 18,962 | 35,796 |
Total liabilities and stockholders' equity | 126,516 | 138,220 |
Related Party | ||
Current assets: | ||
Accounts receivable, net | 2,750 | 3,724 |
Current liabilities: | ||
Accrued expenses and other current liabilities | 1,071 | 945 |
Nonrelated Party | ||
Current assets: | ||
Accounts receivable, net | 1,001 | 808 |
Current liabilities: | ||
Accrued expenses and other current liabilities | $ 10,034 | $ 11,744 |